BONARDI, SIMONE
BONARDI, SIMONE
Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
2010-01-01 Mele, Teresa; Generali, Daniele; Fox, Stephen; Brizzi, Maria Pia; Bersiga, Alessandra; Milani, Manuela; Allevi, Giovanni; Bonardi, Simone; Aguggini, Sergio; Volante, Marco; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian; Berruti, Alfredo
Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer
2017-01-01 Milani, Manuela; Venturini, Sergio; Bonardi, Simone; Allevi, Giovanni; Strina, Carla; Cappelletti, Maria Rosa; Corona, Silvia Paola; Aguggini, Sergio; Bottini, Alberto; Berruti, Alfredo; Jubb, Adrian; Campo, Leticia; Harris, Adrian L.; Gatter, Kevin; Fox, Stephen B.; Generali, Daniele; Roviello, Giandomenico
Phosphorylated ERα, HIF-1α, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer
2009-01-01 Generali, Daniele; Buffa, Francesca M.; Berruti, Alfredo; Brizzi, Maria P.; Campo, Leticia; Bonardi, Simone; Bersiga, Alessandra; Allevi, Giovanni; Milani, Manuela; Aguggini, Sergio; Papotti, Mauro; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L.; Fox, Stephen B.
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen
2011-01-01 Fox, Stephen B; Generali, Daniele; Berruti, Alfredo; Brizzi, Maria P.; Campo, Leticia; Bonardi, Simone; Bersiga, Alessandra; Allevi, Giovanni; Milani, Manuela; Aguggini, Sergio; Mele, Teresa; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients | 1-gen-2010 | Mele, Teresa; Generali, Daniele; Fox, Stephen; Brizzi, Maria Pia; Bersiga, Alessandra; Milani, Manuela; Allevi, Giovanni; Bonardi, Simone; Aguggini, Sergio; Volante, Marco; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian; Berruti, Alfredo | |
| Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer | 1-gen-2017 | Milani, Manuela; Venturini, Sergio; Bonardi, Simone; Allevi, Giovanni; Strina, Carla; Cappelletti, Maria Rosa; Corona, Silvia Paola; Aguggini, Sergio; Bottini, Alberto; Berruti, Alfredo; Jubb, Adrian; Campo, Leticia; Harris, Adrian L.; Gatter, Kevin; Fox, Stephen B.; Generali, Daniele; Roviello, Giandomenico | |
| Phosphorylated ERα, HIF-1α, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer | 1-gen-2009 | Generali, Daniele; Buffa, Francesca M.; Berruti, Alfredo; Brizzi, Maria P.; Campo, Leticia; Bonardi, Simone; Bersiga, Alessandra; Allevi, Giovanni; Milani, Manuela; Aguggini, Sergio; Papotti, Mauro; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L.; Fox, Stephen B. | |
| The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen | 1-gen-2011 | Fox, Stephen B; Generali, Daniele; Berruti, Alfredo; Brizzi, Maria P.; Campo, Leticia; Bonardi, Simone; Bersiga, Alessandra; Allevi, Giovanni; Milani, Manuela; Aguggini, Sergio; Mele, Teresa; Dogliotti, Luigi; Bottini, Alberto; Harris, Adrian L. |